These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21848945)

  • 41. Cell-mediated immunity evaluation in foals infected with virulent equine herpesvirus-1 by multi-parameter flow cytometry.
    Platt R; Sponseller BA; Chiang YW; Roth JA
    Vet Immunol Immunopathol; 2010 Jun; 135(3-4):275-81. PubMed ID: 20116862
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The first reported outbreak of equine herpesvirus myeloencephalopathy in New Zealand.
    McFadden AM; Hanlon D; McKenzie RK; Gibson I; Bueno IM; Pulford DJ; Orr D; Dunowska M; Stanislawek WL; Spence RP; McDonald WL; Munro G; Mayhew IG
    N Z Vet J; 2016 Mar; 64(2):125-34. PubMed ID: 26414406
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inoculation of mares and very young foals with EHV-1 glycoproteins D and B reduces virus shedding following respiratory challenge with EHV-1.
    Foote CE; Raidal SL; Pecenpetelovska G; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2006 May; 111(1-2):97-108. PubMed ID: 16504306
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A review of equid herpesvirus 1 for the veterinary practitioner. Part B: pathogenesis and epidemiology.
    Dunowska M
    N Z Vet J; 2014 Jul; 62(4):179-88. PubMed ID: 24597839
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Respiratory and neurological disease in rabbits experimentally infected with equid herpesvirus 1.
    Kanitz FA; Cargnelutti JF; Anziliero D; Gonçalves KV; Masuda EK; Weiblen R; Flores EF
    Microb Pathog; 2015 Oct; 87():45-50. PubMed ID: 26187161
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Seroprevalence and factors associated with equine herpesvirus type 1 and 4 in Spanish Purebred horses in Spain.
    Cruz F; Fores P; Mughini-Gras L; Ireland J; Moreno MA; Newton JR
    Vet Rec; 2016 Apr; 178(16):398. PubMed ID: 26984900
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Experimental infection with equine herpesvirus type 1 (EHV-1) induces chorioretinal lesions.
    Hussey GS; Goehring LS; Lunn DP; Hussey SB; Huang T; Osterrieder N; Powell C; Hand J; Holz C; Slater J
    Vet Res; 2013 Dec; 44(1):118. PubMed ID: 24308772
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
    Soboll G; Hussey SB; Whalley JM; Allen GP; Koen MT; Santucci N; Fraser DG; Macklin MD; Swain WF; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):81-95. PubMed ID: 16549215
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of quantitative polymerase chain reaction for equine herpesvirus-5 in blood, nasal secretions and bronchoalveolar lavage fluid for the laboratory diagnosis of equine multinodular pulmonary fibrosis.
    Pusterla N; Magdesian KG; Mapes SM; Zavodovskaya R; Kass PH
    Equine Vet J; 2017 Jan; 49(1):34-38. PubMed ID: 26639080
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of equid herpesvirus 1 (EHV-1) AR8 and HH1 strains on BALB-c mice.
    Zanuzzi C; Scrochi M; Fuentealba N; Nishida F; Portiansky E; Muglia C; Gimeno E; Barbeito C; Galosi C
    Arch Virol; 2014 Jan; 159(1):141-5. PubMed ID: 23851654
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outbreak of equine herpesvirus 4 (EHV-4) in Denmark: tracing patient zero and viral characterization.
    Ryt-Hansen P; Johansen VK; Cuicani MM; Larsen LE; Hansen S
    BMC Vet Res; 2024 Jul; 20(1):287. PubMed ID: 38961400
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of equine gammaherpesviruses on breeding farms in Turkey and development of a TaqMan MGB real-time PCR to detect equine herpesvirus 5 (EHV-5).
    Akkutay AZ; Osterrieder N; Damiani A; Tischer BK; Borchers K; Alkan F
    Arch Virol; 2014 Nov; 159(11):2989-95. PubMed ID: 25008897
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immune escape of equine herpesvirus 1 and other herpesviruses of veterinary importance.
    van der Meulen KM; Favoreel HW; Pensaert MB; Nauwynck HJ
    Vet Immunol Immunopathol; 2006 May; 111(1-2):31-40. PubMed ID: 16472872
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differences in replication kinetics and cell tropism between neurovirulent and non-neurovirulent EHV1 strains during the acute phase of infection in horses.
    Gryspeerdt AC; Vandekerckhove AP; Garré B; Barbé F; Van de Walle GR; Nauwynck HJ
    Vet Microbiol; 2010 May; 142(3-4):242-53. PubMed ID: 19926232
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of equid herpesviruses 2 and 5 in a herd of 266 Lipizzaners in association with ocular findings.
    Rushton JO; Kolodziejek J; Tichy A; Nell B; Nowotny N
    Vet Microbiol; 2013 May; 164(1-2):139-44. PubMed ID: 23434188
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An equine herpesvirus type 1 recombinant with a deletion in the gE and gI genes is avirulent in young horses.
    Matsumura T; Kondo T; Sugita S; Damiani AM; O'Callaghan DJ; Imagawa H
    Virology; 1998 Mar; 242(1):68-79. PubMed ID: 9501037
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuropathogenic and non-neuropathogenic genotypes of Equid Herpesvirus type 1 in Argentina.
    Vissani MA; Becerra ML; Olguín Perglione C; Tordoya MS; Miño S; Barrandeguy M
    Vet Microbiol; 2009 Nov; 139(3-4):361-4. PubMed ID: 19589651
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A vectored equine herpesvirus type 1 (EHV-1) vaccine elicits protective immune responses against EHV-1 and H3N8 equine influenza virus.
    Van de Walle GR; May MA; Peters ST; Metzger SM; Rosas CT; Osterrieder N
    Vaccine; 2010 Jan; 28(4):1048-55. PubMed ID: 19897066
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of immune responses following infection of ponies with an EHV-1 ORF1/2 deletion mutant.
    Soboll Hussey G; Hussey SB; Wagner B; Horohov DW; Van de Walle GR; Osterrieder N; Goehring LS; Rao S; Lunn DP
    Vet Res; 2011 Feb; 42(1):23. PubMed ID: 21314906
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vaccination of ponies with the IE gene of EHV-1 in a recombinant modified live vaccinia vector protects against clinical and virological disease.
    Soboll G; Breathnach CC; Kydd JH; Hussey SB; Mealey RM; Lunn DP
    Vet Immunol Immunopathol; 2010 May; 135(1-2):108-117. PubMed ID: 20018383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.